Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 507

1.

Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing.

Vetter VL, Elia J, Erickson C, Berger S, Blum N, Uzark K, Webb CL; American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee.; American Heart Association Council on Cardiovascular Nursing..

Circulation. 2008 May 6;117(18):2407-23. doi: 10.1161/CIRCULATIONAHA.107.189473. No abstract available. Erratum in: Circulation. 2009 Aug 18;120(7):e55-9.

2.

American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD: May 16, 2008.

American Academy of Pediatrics/American Heart Association..

J Dev Behav Pediatr. 2008 Aug;29(4):335. doi: 10.1097/DBP.0b013e31318185dc14. No abstract available.

PMID:
18698199
3.

Reexamining the emperor's new clothes: ambiguities in current cardiac screening recommendations for youth with attention deficit hyperactivity disorder.

Leslie LK, Alexander ME, Trikalinos TA, Cohen JT, Parsons SK, Newburger JW.

Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):134-7. doi: 10.1161/CIRCOUTCOMES.108.825232. No abstract available.

4.

Primary prevention of cardiovascular disease in nursing practice: focus on children and youth: a scientific statement from the American Heart Association Committee on Atherosclerosis, Hypertension, and Obesity in Youth of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council on Nutrition, Physical Activity, and Metabolism.

Hayman LL, Meininger JC, Daniels SR, McCrindle BW, Helden L, Ross J, Dennison BA, Steinberger J, Williams CL; American Heart Association Committee on Atherosclerosis, Hypertension, and Obesity in Youth of the Council on Cardiovascular Disease in the Young.; American Heart Association Council on Cardiovascular Nursing.; American Heart Association Council on Epidemiology and Prevention.; American Heart Association Council on Nutrition, Physical Activity, and Metabolism..

Circulation. 2007 Jul 17;116(3):344-57. No abstract available.

5.

Impact of the American Heart Association scientific statement on screening electrocardiograms and stimulant medications.

Thomas PE, Carlo WF, Decker JA, Cannon BC, Kertesz NJ, Friedman RA, Kim JJ.

Arch Pediatr Adolesc Med. 2011 Feb;165(2):166-70. doi: 10.1001/archpediatrics.2010.278.

PMID:
21300657
6.

Update on adult attention-deficit/hyperactivity disorder.

Hammerness P, Surman C, Miller K.

Curr Neurol Neurosci Rep. 2008 Nov;8(6):484-9.

PMID:
18957185
7.

. . . and recommending an ECG starting stimulant medicines in kids.

[No authors listed]

Child Health Alert. 2008 Sep;26:2-3. No abstract available.

PMID:
18953696
8.
9.
10.

Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.

Perrin JM, Friedman RA, Knilans TK; Black Box Working Group.; Section on Cardiology and Cardiac Surgery..

Pediatrics. 2008 Aug;122(2):451-3. doi: 10.1542/peds.2008-1573. No abstract available.

PMID:
18676566
11.

Medications for attention deficit hyperactivity disorder: cardiovascular concerns.

Wooltorton E.

CMAJ. 2006 Jul 4;175(1):29. No abstract available.

12.

Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group.

Canter CE, Shaddy RE, Bernstein D, Hsu DT, Chrisant MR, Kirklin JK, Kanter KR, Higgins RS, Blume ED, Rosenthal DN, Boucek MM, Uzark KC, Friedman AH, Young JK; American Heart Association Council on Cardiovascular Disease in the Young.; American Heart Association Council on Clinical Cardiology.; American Heart Association Council on Cardiovascular Nursing.; American Heart Association Council on Cardiovascular Surgery and Anesthesia.; Quality of Care and Outcomes Research Interdisciplinary Working Group..

Circulation. 2007 Feb 6;115(5):658-76. Review. Erratum in: Circulation. 2007 Apr 3;115(13):e385. Friedman, Allen H [corrected to Friedman, Alan H].

13.
14.

Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations.

Hammerness PG, Perrin JM, Shelley-Abrahamson R, Wilens TE.

J Am Acad Child Adolesc Psychiatry. 2011 Oct;50(10):978-90. doi: 10.1016/j.jaac.2011.07.018. Review.

PMID:
21961773
15.

Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.

Winterstein AG, Gerhard T, Shuster J, Johnson M, Zito JM, Saidi A.

Pediatrics. 2007 Dec;120(6):e1494-501.

PMID:
18055666
16.

Stimulant medications and attention deficit-hyperactivity disorder.

Cohen AL, Jhung MA, Budnitz DS.

N Engl J Med. 2006 May 25;354(21):2294-5. No abstract available.

17.

Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism.

Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, Mietus-Snyder ML; American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism..

Circulation. 2009 Feb 3;119(4):628-47. doi: 10.1161/CIRCULATIONAHA.108.191394. No abstract available.

18.

ADHD drugs and cardiovascular risk.

Rappley MD, Moore JW, Dokken D.

N Engl J Med. 2006 May 25;354(21):2296-8; author reply 2296-8. No abstract available.

PMID:
16729375
19.

Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health).

Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T; American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology.; American Heart Association Stroke Council.; American Heart Association Council on Cardiovascular Nursing.; American College of Cardiology Foundation..

Circulation. 2008 Sep 2;118(10):1080-111. doi: 10.1161/CIRCULATIONAHA.107.189375. No abstract available. Erratum in: Circulation. 2009 Mar 31;119(12):e380.

20.
Items per page

Supplemental Content

Support Center